Why the study?
To evaluate whether Shexiang Tongxin dripping pills improve coronary microcirculation disorder and cardiac dysfunction in a porcine model of myocardial ischemia-reperfusion injury.
Does Shexiang Tongxin dripping pills improve coronary microcirculation disorder and cardiac dysfunction in a porcine model of myocardial ischemia-reperfusion injury?
Does Shexiang Tongxin dripping pills improve coronary microcirculation disorder and cardiac dysfunction in a porcine model of myocardial ischemia-reperfusion injury?
In a porcine model, Shexiang Tongxin dripping pills improved coronary microcirculation and cardiac dysfunction after myocardial ischemia-reperfusion, potentially by modulating inflammation and energy metabolism pathways.
Preclinical support for STDP in post-ischemic CMD; human trials needed before any clinical consideration.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: